# US 2012/0252040 A1 · Kit for diagnosing prostate cancer and diagnosis method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252040 A1
- Document ID: US20120252040A1
- Status: Published application
- Kind: A1
- Application number: 13/516,460
- Filed: 2010-11-29
- Published: 2012-10-04
- Earliest claimed: 2009-12-17
- Assignees: Cell & Bio Co., Ltd.
- Inventors: Kang Jun Yoon; Young Sook Son; Hyun Sook Hong; Hyeongwon Choi
- Web page: https://patentgrep.com/patent/US20120252040A1

## CPC

- G01N 33/57555: of the prostate
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a kit and method for diagnosing prostate cancer, which use an antibody to prostate-specific antigen (PSA) to detect PSA in human urine. More specifically, the invention relates to a kit for diagnosing prostate cancer, which comprises an antibody to PSA and uses human urine as a sample, and to a method for diagnosing prostate cancer, which comprises brining a human urine sample into contact with an antibody to PSA in order to detect PSA in the sample.

## Claims

### Claim 1

A method for diagnosing prostate cancer, comprising the steps of:
(a) determining the amount of prostate-specific antigen (PSA) in a sample obtained from the urine of a subject;
(b) comparing the amount determined in the step (a) with a reference amount; and
(c) diagnosing whether the subject has prostate cancer, based on the result obtained in the step (b).

### Claim 2 (depends on 1)

The method of claim 1, wherein the method is performed in vitro.

### Claim 3 (depends on 1)

The method of claim 1, wherein the amount of PSA in the step (a) is determined using a PSA-specific antibody.

### Claim 4 (depends on 1)

The method of claim 1, wherein the reference amount in the step (b) is the amount of PSA determined for a urine sample collected from a normal person.

### Claim 5 (depends on 4)

The method of claim 4, wherein the subject is diagnosed as having prostate cancer, if the amount of PSA in the step (a) is smaller than the reference amount in the step (b).

### Claim 6 (depends on 1)

The method of claim 1, wherein the subject is diagnosed as having prostate cancer, if the amount of PSA in step (a) is about 10 ng/ml or less.

### Claim 7 (depends on 1)

A prostate cancer-diagnosing kit for use in the method of claim 1, wherein the kit comprises a PSA-specific antibody and uses urine as a sample.

### Claim 8 (depends on 7)

The kit of claim 7, wherein the kit further comprises an instruction for use which includes information that enables to determine the presence or absence of prostate cancer based on the determined amount of PSA in the urine sample.

### Claim 9 (depends on 7)

The kit of claim 7, wherein the kit further comprises an instruction for use, indicating that prostate cancer is diagnosed when the determined amount of PSA in the urine sample is about 10 ng/ml or less.
